- Country: Brazil
- Summary: Process for Potential Purchase of Medicines from Groups 09.J.02.A (Antimicotics for Systemic Use) and 09.J.01.D (Other Beta-Lactam Antibacterials), under the Terms of the Table Below, as Specified...
- BRT Ref No: 98326764
- Deadline: 18 Mar 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90026/2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Process for potential purchase of medicines from groups 09.J.02.A (ANTIMICOTICS FOR SYSTEMIC USE) and 09.J.01.D (OTHER BETA-LACTAM ANTIBACTERIALS), under the terms of the table below, according to specifications and quantities contained in Annex I of the Notice.
UASG Code19981d172c851bd4e8a1788d5726c2d3: 926119
Notice from: 03/06/2024 from 08:00 to 12:00 and from 14:00 to 17:00
Proposal Delivery: from 03/06/2024 to 08:00
AMPHOTERICIN B, DOSAGE 100 MG, ADDITIONAL CHARACTERISTICS COLLOIDAL, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION
Quantity: 1008
AMPHOTERICIN B, DOSAGE 10019981d172c851bd4e8a1788d5726c2d3MG, ADDITIONAL CHARACTERISTICS COLLOIDAL, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 336
AMPHOTERICIN B, DOSAGE 50 MG, ADDITIONAL CHARACTERISTICS LIPOSOMAL, INJECTABLE APPLICATION
Quantity: 5342
AMPHOTERICIN B, DOSAGE 50 MG, CHARACTERISTICS ADDITIONAL LIPOSOMAL TERISTICS, INJECTABLE APPLICATION
QuanQuantity: 1780
AMPHOTERICIN B, DOSAGE 50 MG, INJECTABLE APPLICATION
Quantity: 1306
ANIDULAFUNGINE, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 5242
ANIDULAFUNGINE, CONCENTRATION 100 MG, PHARMACEUTICAL FORM EUTICA LYOPHIL POWDER FOR INJECTION
Quantity : 1747
CASPOFUNGIN ACETATE,19981d172c851bd4e8a1788d5726c2d3CONCENTRATION 70 MG, INJECTABLE PRESENTATION
Quantity: 5242
CASPOFUNGIN ACETATE, CONCENTRATION 70 MG, INJECTABLE PRESENTATION
Quantity: 1747
MICAFUNGIN, SODIUM COMPOSITION, 100 MG CONCENTRATION, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 5242
MICAFUNGIN, SODIUM COMPOSITION , CONCENTRA19981d172c851bd4e8a1788d5726c2d3CAO 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTABLE
Quantity: 1747
CASPOFUNGIN ACETATE, CONCENTRATION 50 MG, INJECTABLE PRESENTATION
Quantity: 5242
CASPOFUNGIN ACETATE, CONCENTRATION 50 MG, INJECTABLE PRESENTATION
Quantity: 1747
MICAFUNGIN, SODIUM COMPOSITION, CONCENTRATION 50 MG, FAR FORM19981d172c851bd4e8a1788d5726c2d3MACEUTICA LYOPHIL POWDER FOR INJECTION
Quantity: 10484
MICAFUNGINE, COMPOSITION... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINProcess for Potential Purchase of Medicines from Groups 09.J.02.A (Antimicotics for Systemic Use) and 09.J.01.D (Other Beta-Lactam Antibacterials), under the Terms of the Table Below, as Specified... - Brazil Tender
The FEDERAL DISTRICT GOVERNMENT - GDF, a Government sector organization in Brazil, has announced a new tender for Process for Potential Purchase of Medicines from Groups 09.J.02.A (Antimicotics for Systemic Use) and 09.J.01.D (Other Beta-Lactam Antibacterials), under the Terms of the Table Below, as Specified.... This tender is published on BrazilTenders under BRT Ref No: 98326764 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-03-18.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
